ID

43042

Descrição

A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer (ENTHUSE M0) see http://clinicaltrials.gov/ct2/show/study/NCT00626548

Link

http://clinicaltrials.gov/ct2/show/study/NCT00626548

Palavras-chave

  1. 22/11/2011 22/11/2011 -
  2. 22/11/2011 22/11/2011 -
  3. 27/03/2014 27/03/2014 - Martin Dugas
  4. 13/04/2014 13/04/2014 - Julian Varghese
  5. 17/09/2021 17/09/2021 -
Transferido a

17 de setembro de 2021

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility DRKS00003883 NCT00626548 Prostate Cancer

Eligibility NCT00626548

  1. StudyEvent: Eligibility
    1. Eligibility NCT00626548
Inclusion criteria
Descrição

Inclusion criteria

Alias
UMLS CUI-1
C1512693
18 Years and older
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI-1
C0001779
Male
Descrição

Gender Male

Tipo de dados

boolean

Alias
UMLS CUI-1
C0086582
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has NOT spread to the other parts of the body (metastases). Patients with lymph node involvement may be eligible if specified criteria is met.
Descrição

Prostate Cancer

Tipo de dados

boolean

Alias
UMLS CUI-1
C0600139
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
Descrição

PSA

Tipo de dados

boolean

Alias
UMLS CUI-1
C0138741
Currently receiving treatment with surgical or medical castration
Descrição

Castration

Tipo de dados

boolean

Alias
UMLS CUI-1
C0007347
Exclusion criteria
Descrição

Exclusion criteria

Alias
UMLS CUI-1
C0680251
Currently using opiate based pain killers for cancer related pain
Descrição

Opiate

Tipo de dados

boolean

Alias
UMLS CUI-1
C0376196
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
Descrição

Previous chemotherapy

Tipo de dados

boolean

Alias
UMLS CUI-1
C1514457
Suffering from heart failure or had a myocardial infarction within last 6 months
Descrição

Heart disease

Tipo de dados

boolean

Alias
UMLS CUI-1
C0018799
A history of epilepsy or seizures
Descrição

Epilepsy

Tipo de dados

boolean

Alias
UMLS CUI-1
C0014544

Similar models

Eligibility NCT00626548

  1. StudyEvent: Eligibility
    1. Eligibility NCT00626548
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Inclusion criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years and older
boolean
C0001779 (UMLS CUI-1)
Gender Male
Item
Male
boolean
C0086582 (UMLS CUI-1)
Prostate Cancer
Item
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has NOT spread to the other parts of the body (metastases). Patients with lymph node involvement may be eligible if specified criteria is met.
boolean
C0600139 (UMLS CUI-1)
PSA
Item
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
boolean
C0138741 (UMLS CUI-1)
Castration
Item
Currently receiving treatment with surgical or medical castration
boolean
C0007347 (UMLS CUI-1)
Item Group
Exclusion criteria
C0680251 (UMLS CUI-1)
Opiate
Item
Currently using opiate based pain killers for cancer related pain
boolean
C0376196 (UMLS CUI-1)
Previous chemotherapy
Item
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
boolean
C1514457 (UMLS CUI-1)
Heart disease
Item
Suffering from heart failure or had a myocardial infarction within last 6 months
boolean
C0018799 (UMLS CUI-1)
Epilepsy
Item
A history of epilepsy or seizures
boolean
C0014544 (UMLS CUI-1)

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial